BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17263630)

  • 1. Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model.
    Kish-Catalone T; Pal R; Parrish J; Rose N; Hocker L; Hudacik L; Reitz M; Gallo R; Devico A
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):33-42. PubMed ID: 17263630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5.
    Kish-Catalone TM; Lu W; Gallo RC; DeVico AL
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1497-509. PubMed ID: 16569870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
    Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
    Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of a simian-human immunodeficiency virus strain resistant to a vaginal microbicide in macaques.
    Dudley DM; Wentzel JL; Lalonde MS; Veazey RS; Arts EJ
    J Virol; 2009 May; 83(10):5067-76. PubMed ID: 19279098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
    Veazey RS; Klasse PJ; Schader SM; Hu Q; Ketas TJ; Lu M; Marx PA; Dufour J; Colonno RJ; Shattock RJ; Springer MS; Moore JP
    Nature; 2005 Nov; 438(7064):99-102. PubMed ID: 16258536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical nonnucleoside reverse transcriptase inhibitor MC 1220 partially prevents vaginal RT-SHIV infection of macaques.
    Stolte-Leeb N; Loddo R; Antimisiaris S; Schultheiss T; Sauermann U; Franz M; Mourtas S; Parsy C; Storer R; La Colla P; Stahl-Hennig C
    AIDS Res Hum Retroviruses; 2011 Sep; 27(9):933-43. PubMed ID: 21332419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission.
    Barouch DH; Klasse PJ; Dufour J; Veazey RS; Moore JP
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8694-8. PubMed ID: 22586094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C5A Protects Macaques from Vaginal Simian-Human Immunodeficiency Virus Challenge.
    Veazey RS; Chatterji U; Bobardt M; Russell-Lodrigue KE; Li J; Wang X; Gallay PA
    Antimicrob Agents Chemother; 2016 Jan; 60(1):693-8. PubMed ID: 26552985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates.
    Kim CN; Adams DR; Bashirian S; Butera S; Folks TM; Otten RA
    J Med Primatol; 2006 Aug; 35(4-5):210-6. PubMed ID: 16872284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor.
    Veazey RS; Ketas TJ; Dufour J; Moroney-Rasmussen T; Green LC; Klasse PJ; Moore JP
    J Infect Dis; 2010 Sep; 202(5):739-44. PubMed ID: 20629537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIV-150/zinc acetate gel inhibits cell-associated simian-human immunodeficiency virus reverse transcriptase infection in a macaque vaginal explant model.
    Barnable P; Calenda G; Bonnaire T; Menon R; Levendosky K; Gettie A; Blanchard J; Cooney ML; Fernández-Romero JA; Zydowsky TM; Teleshova N
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3829-37. PubMed ID: 25870063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decline in CCL3-5 chemokine gene expression during primary simian-human immunodeficiency virus infection.
    Zhao W; Pahar B; Borda JT; Alvarez X; Sestak K
    PLoS One; 2007 Aug; 2(8):e726. PubMed ID: 17684570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor.
    Veazey RS; Springer MS; Marx PA; Dufour J; Klasse PJ; Moore JP
    Nat Med; 2005 Dec; 11(12):1293-4. PubMed ID: 16273102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
    Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
    J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
    Le Grand R; Dereuddre-Bosquet N; Dispinseri S; Gosse L; Desjardins D; Shen X; Tolazzi M; Ochsenbauer C; Saidi H; Tomaras G; Prague M; Barnett SW; Thiebaut R; Cope A; Scarlatti G; Shattock RJ
    J Virol; 2016 Jun; 90(11):5315-5328. PubMed ID: 27009957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of vaginal transmission of a simian human immunodeficiency virus (SHIV) encoding the reverse transcriptase gene from HIV-1 in Chinese rhesus macaques.
    Pal R; Nuttall J; Galmin L; Weiss D; Chung HK; Romano J
    Virology; 2009 Mar; 386(1):102-8. PubMed ID: 19195672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques.
    Malcolm RK; Veazey RS; Geer L; Lowry D; Fetherston SM; Murphy DJ; Boyd P; Major I; Shattock RJ; Klasse PJ; Doyle LA; Rasmussen KK; Goldman L; Ketas TJ; Moore JP
    Antimicrob Agents Chemother; 2012 May; 56(5):2251-8. PubMed ID: 22330914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of the Protein Microbicide 5P12-RANTES in Sheep following Single-Dose Vaginal Gel Administration.
    McBride JW; Dias N; Cameron D; Offord RE; Hartley O; Boyd P; Kett VL; Malcolm RK
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide.
    Cheng-Mayer C; Huang Y; Gettie A; Tsai L; Ren W; Shakirzyanova M; Sina ST; Trunova N; Blanchard J; Jenkins LM; Lo Y; Schito ML; Appella E
    AIDS; 2011 Sep; 25(15):1833-41. PubMed ID: 21750420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiniCD4 microbicide prevents HIV infection of human mucosal explants and vaginal transmission of SHIV(162P3) in cynomolgus macaques.
    Dereuddre-Bosquet N; Morellato-Castillo L; Brouwers J; Augustijns P; Bouchemal K; Ponchel G; Ramos OH; Herrera C; Stefanidou M; Shattock R; Heyndrickx L; Vanham G; Kessler P; Le Grand R; Martin L
    PLoS Pathog; 2012; 8(12):e1003071. PubMed ID: 23236282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.